Newborn infants are highly susceptible to lung infection and inflammation. In preterm infants, infection prevents normal lung development and leads to bronchopulmonary dysplasia. Term newborns are also at risk, with bacterial pneumonia a leading cause of neonatal morbidity and mortality both in the U.S. and worldwide. In older children and adults, a specialized innate immune system protects the lung from pathogens and injury related to infection. While innate immunity in the newborn lung is clearly diminished, we do not yet clearly understand the molecular and cellular mechanisms putting these populations at risk. Identifying these key mechanisms will allow development of new therapies for preventing and treating neonatal disease. In the lung, macrophages are the key immune cell responsible for ingesting and removing particles, killing pathogens, recruiting additional immune cells, and promoting healing following injury. However, the role of macrophages in newborn lung innate immunity has been uncharacterized. Our previous work demonstrated using innovative mouse models that macrophages populate the fetal lung from the earliest stages of lung formation. These fetal lung macrophages are capable of responding to microbial substances well before they would be expected to have contact with the external environment. We also showed that macrophage activation was required and sufficient for causing inflammation in the fetal lung. In addition, fetal lung macrophage activation was the key initial step in inflammation-mediated arrest in lung development. Subsequent work in our lab showed macrophage derived IL-1 plays a key role in inhibiting normal epithelial-mesenchymal integrations during lung morphogenesis. However, multiple expression and function of multiple components of the macrophage immune response appear to be developmentally regulated, with increased expression in more mature lungs. We therefore hypothesize that developmental maturation of lung macrophages determines how the inflammatory response causes lung disease. To test our hypothesis, we propose complementary approaches to better understand the molecular mechanisms regulating normal lung macrophage maturation and differentiation. We will also test how exposure of developing macrophages to activating stimuli not only generates an inflammatory response but also alters the normal transcriptional program controlling macrophage differentiation and maturation. Because early activation appears to accelerate cell maturation, we will test how premature maturation affects macrophage cell biology. These experiments will identify key basic mechanisms regulating how the lung innate immune system develops in both normal and disease settings. Our findings will therefore lay the foundation for future translational and therapeutic discovery and applications to improve pediatric health.

Public Health Relevance

Newborns are highly susceptible to respiratory infections and lung injury. Our inability to prevent or treat newborn lung diseases significantly impacts society. New discoveries and insights into how the lung immune system develops and how we might better protect newborn lungs from infections will therefore greatly improve child health.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL126703-01
Application #
8859454
Study Section
Lung Injury, Repair, and Remodeling Study Section (LIRR)
Program Officer
Lin, Sara
Project Start
2015-05-15
Project End
2019-03-31
Budget Start
2015-05-15
Budget End
2016-03-31
Support Year
1
Fiscal Year
2015
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Pediatrics
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Hoffman, Hal M; Broderick, Lori (2017) Editorial: It Just Takes One: Somatic Mosaicism in Autoinflammatory Disease. Arthritis Rheumatol 69:253-256
Medal, Rachel M; Im, Amanda M; Yamamoto, Yasutoshi et al. (2017) The innate immune response in fetal lung mesenchymal cells targets VEGFR2 expression and activity. Am J Physiol Lung Cell Mol Physiol 312:L861-L872
McCoy, Alyssa M; Herington, Jennifer L; Stouch, Ashley N et al. (2017) IKK? Activation in the Fetal Lung Mesenchyme Alters Lung Vascular Development but Not Airway Morphogenesis. Am J Pathol 187:2635-2644
Lakhdari, Omar; McAllister, Christopher S; Wang, Michael et al. (2016) TLR3 signaling is downregulated by a MAVS isoform in epithelial cells. Cell Immunol 310:205-210
Benjamin, John T; van der Meer, Riet; Im, Amanda M et al. (2016) Epithelial-Derived Inflammation Disrupts Elastin Assembly and Alters Saccular Stage Lung Development. Am J Pathol 186:1786-1800
Stouch, Ashley N; McCoy, Alyssa M; Greer, Rachel M et al. (2016) IL-1? and Inflammasome Activity Link Inflammation to Abnormal Fetal Airway Development. J Immunol 196:3411-20
Han, Wei; Zaynagetdinov, Rinat; Yull, Fiona E et al. (2015) Molecular imaging of folate receptor ?-positive macrophages during acute lung inflammation. Am J Respir Cell Mol Biol 53:50-9
Greer, Rachel M; Miller, J Davin; Okoh, Victor O et al. (2014) Epithelial-mesenchymal co-culture model for studying alveolar morphogenesis. Organogenesis 10:
Stouch, Ashley N; Zaynagetdinov, Rinat; Barham, Whitney J et al. (2014) I?B kinase activity drives fetal lung macrophage maturation along a non-M1/M2 paradigm. J Immunol 193:1184-93
Plosa, Erin J; Young, Lisa R; Gulleman, Peter M et al. (2014) Epithelial ?1 integrin is required for lung branching morphogenesis and alveolarization. Development 141:4751-62